))
The Logistics of Cell & Gene Therapy – From Benchmarking to Standardization (Part 1)
Manage episode 418077912 series 3554424
Content provided by Quick Group of Companies. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Quick Group of Companies or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Medical care and scientific research offer some of the most challenging – and developing – areas for global supply chain logistics. And few are more significant– in terms of potential for improving human life and logistics precision required – than Cell & Gene Therapy or CGT.
These CGT “medical miracles” bring logistics opportunities and challenges, around timing, temperature, chain of identity, synchronization, integration, scale, back up planning, and more.
So, what is required – logistically – to help ensure CGT clinical trials and personalized therapies get handled safely, securely, and on time?
QuickSTAT's Global Head of Strategy for CGT and DTP, Mike Sweeney and Senior VP of Commercial Operations Scott Ohanesian explain.
For more information on clinical trial logistics, visit our website at quickstat.com.
4 episodes
Share
